| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3348744 | Diagnostic Microbiology and Infectious Disease | 2007 | 4 Pages |
Abstract
Infliximab, a tumor necrosis factor-α inhibitor, is increasingly used for the therapy of different inflammatory conditions. We report the first case of cryptococcal meningitis in a patient treated with infliximab and other immunosuppressive agents, and review a further 5 reported cryptococcal infections. All of them involved fungal pneumonia. Outcome was favorable in all cases.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Patricia Muñoz, Maddalena Giannella, Maricela Valerio, Teresa Soria, Fernando Díaz, Javier Lopez Longo, Emilio Bouza,